Boston Scientific (NYSE: BSX) director adds 5,000 shares in open-market buy
Rhea-AI Filing Summary
Boston Scientific Corp director Edward J. Ludwig purchased 5,000 shares of common stock on July 31, 2026 at an average price of $45.4799 per share. After this open-market or private transaction, he directly owns 30,359 shares. The trade was not reported under a Rule 10b5-1 plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 5,000 shares
Net Buy
1 txn
Insider
LUDWIG EDWARD J
Role
Director
Bought
5,000 shs ($227K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,000 | $45.4799 | $227K |
Holdings After Transaction:
Common Stock — 30,359 shares (Direct)
Key Figures
Shares purchased: 5,000 shares
Purchase price: $45.4799 per share
Shares owned after transaction: 30,359 shares
+1 more
4 metrics
Shares purchased
5,000 shares
Common Stock transaction on July 31, 2026
Purchase price
$45.4799 per share
Average price for the 5,000-share purchase
Shares owned after transaction
30,359 shares
Directly held Boston Scientific common stock after the purchase
Net insider buying
5,000 shares
Net buy shares reported in transactionSummary (net-buy direction)
Key Terms
Rule 10b5-1, open market or private transaction, direct or indirect ownership
3 terms
Rule 10b5-1 regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open market or private transaction market
"transaction_code_description: Purchase in open market or private transaction"
direct or indirect ownership financial
"direct_or_indirect uses D/I for Direct/Indirect ownership type"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Edward J. Ludwig report for BSX?
Edward J. Ludwig reported a purchase of 5,000 shares of Boston Scientific common stock on July 31, 2026. This was recorded as an open-market or private transaction and increased his directly held stake in the company.
What are Edward J. Ludwig’s total BSX holdings after this trade?
Following the reported transaction, Edward J. Ludwig directly owns 30,359 shares of Boston Scientific common stock. This total reflects his position immediately after purchasing 5,000 shares on July 31, 2026, as disclosed in the Form 4 data.
Is Edward J. Ludwig’s BSX ownership direct or indirect after the trade?
The filing classifies his post-transaction holdings as direct ownership. The 30,359 Boston Scientific shares reported following the purchase are coded with ownership type "D" for Direct, with no nature-of-ownership footnote qualifiers attached.
What is the net effect of the reported insider trading activity in BSX?
The net effect is a net buy of 5,000 shares by Edward J. Ludwig. Transaction summary data shows one purchase transaction, no sales, and net-buy direction, increasing his direct holdings of Boston Scientific common stock to 30,359 shares.